Home › Funds › Atom Investors LP › SNDX

Atom Investors LP position in SNDX

SYNDAX PHARMACEUTICALS INC · Health Care

Atom Investors LP reported holding 162,524 shares of SNDX (SYNDAX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.6M, representing 0.32% of its reported portfolio and ranking #48 among its reported holdings. Atom Investors LP has disclosed SNDX holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)162.52K sh
Reported value held$3.55M
Portfolio Weight0.32%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Atom Investors LP's SNDX position evolved

Atom Investors LP first disclosed a stake in SNDX in Q4 2024 at 62,795 shares (US$830K). The position peaked in Q1 2026 at 155,965 shares, worth US$3.6M. Across 6 filings, Atom Investors LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 162,524 shares valued at US$3.6M — an increase of 6,559 shares quarter over quarter.. Notable position changes include a 77% trim in Q2 2025 (shares rose 64% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 62.80K $830.15K New
Q1 2025 57.27K $703.61K Reduce
Q2 2025 13.10K $122.72K Reduce
Q4 2025 141.67K $2.98M New
Q1 2026 155.97K $3.64M Add
Q2 2026 162.52K $3.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SNDX and 13F data

SNDX (SYNDAX PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in SNDX — the largest reported positions include Kynam Capital Management, LP (US$176.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$61.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SNDX

All SNDX fund holders →

FAQ

How long has Atom Investors LP held SNDX?

Atom Investors LP has disclosed SNDX holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

What is Atom Investors LP's current position in SNDX?

As of Q2 2026, Atom Investors LP holds 162.52K shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $3.55M, representing 0.32% of its reported portfolio and ranking #48.

Has Atom Investors LP been buying or selling SNDX?

In the latest 13F filing (Q2 2026), Atom Investors LP increased its position in SNDX. The position peaked in Q1 2026 at 155.97K shares.

Which other funds hold SNDX?

Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.